SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Erica Novo, Stefania Cannito, Claudia Paternostro, Claudia Bocca, Antonella Miglietta, Maurizio Parola, Cellular and molecular mechanisms in liver fibrogenesis, Archives of Biochemistry and Biophysics, 2014, 548, 20

    CrossRef

  2. 2
    Youcai Tang, Anping Chen, Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling, Laboratory Investigation, 2014, 94, 5, 503

    CrossRef

  3. 3
    Elena Arriazu, Marina Ruiz de Galarreta, Francisco Javier Cubero, Marta Varela-Rey, María Pilar Pérez de Obanos, Tung Ming Leung, Aritz Lopategi, Aitor Benedicto, Ioana Abraham-Enachescu, Natalia Nieto, Extracellular Matrix and Liver Disease, Antioxidants & Redox Signaling, 2014, 21, 7, 1078

    CrossRef

  4. 4
    Hwan-Woo Park, Haeli Park, Seung-Hyun Ro, Insook Jang, Ian A. Semple, David N. Kim, Myungjin Kim, Myeongjin Nam, Deqiang Zhang, Lei Yin, Jun Hee Lee, Hepatoprotective role of Sestrin2 against chronic ER stress, Nature Communications, 2014, 5,

    CrossRef

  5. 5
    Caroline C. Duwaerts, Jacquelyn J. Maher, Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 119

    CrossRef

  6. 6
    Ming-Yi Xu, Jun-Jie Hu, Jie Shen, Mei-Ling Wang, Qing-Qing Zhang, Ying Qu, Lun-Gen Lu, Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014,

    CrossRef

  7. 7
    Zhengping Zhang, Zhongfei Gao, Wei Hu, Shan Yin, Chunming Wang, Yuhui Zang, Jiangning Chen, Junfeng Zhang, Lei Dong, 3,3′-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression, British Journal of Pharmacology, 2013, 170, 3
  8. 8
    Bianca Hemmeryckx, Marijke Gaekens, David J. Gallacher, Hua Rong Lu, Henri Roger Lijnen, Effect of Rosiglitazone on Liver Structure and Function in Genetically Diabetic Akita Mice, Basic & Clinical Pharmacology & Toxicology, 2013, 113, 5
  9. 9
    Takaaki Sugihara, Masahiko Koda, Manabu Kishina, Jun Kato, Shiho Tokunaga, Tomomitsu Matono, Masaru Ueki, Yoshikazu Murawaki, Fatty liver Shionogi-ob/ob mouse: A new candidate for a non-alcoholic steatohepatitis model, Hepatology Research, 2013, 43, 5
  10. 10
    Lina Abu-Tair, Sarit Doron, Mahmud Mahamid, Johnny Amer, Rifaat Safadi, Leptin modulates lymphocytes' adherence to hepatic stellate cells is associated with oxidative status alterations, Mitochondrion, 2013, 13, 5, 473

    CrossRef

  11. 11
    Wei Zhang, Minghui Niu, Kunfeng Yan, Xuguang Zhai, Qian Zhou, Li Zhang, Yajun Zhou, Stat3 pathway correlates with the roles of leptin in mouse liver fibrosis and sterol regulatory element binding protein-1c expression of rat hepatic stellate cells, The International Journal of Biochemistry & Cell Biology, 2013, 45, 3, 736

    CrossRef

  12. 12
    Xuguang Zhai, Kunfeng Yan, Jiye Fan, Minghui Niu, Qian Zhou, Yan Zhou, Hongshan Chen, Yajun Zhou, The β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosis, British Journal of Pharmacology, 2013, 169, 1
  13. 13
    Valerio Nobili, Guido Carpino, Anna Alisi, Antonio Franchitto, Gianfranco Alpini, Rita De Vito, Paolo Onori, Domenico Alvaro, Eugenio Gaudio, Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease, Hepatology, 2012, 56, 6
  14. 14
    Ben Schroyen, Eduardo L. Guimarães, Laurent Dollé, Stephanie Coulon, Christophe Empsen, Marc Nyssen, Anja Geerts, Isabelle Colle, Albert Geerts, Leo A. van Grunsven, Leptin-mediated reactive oxygen species production does not significantly affect primary mouse hepatocyte functions in vitro, European Journal of Gastroenterology & Hepatology, 2012, 24, 12, 1370

    CrossRef

  15. 15
    Eugenio Gaudio, Valerio Nobili, Antonio Franchitto, Paolo Onori, Guido Carpino, Nonalcoholic fatty liver disease and atherosclerosis, Internal and Emergency Medicine, 2012, 7, S3, 297

    CrossRef

  16. 16
    Mangesh R. Pagadala, Claudia O. Zein, Srinivasan Dasarathy, Lisa M. Yerian, Rocio Lopez, Arthur J. McCullough, Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease, Digestive Diseases and Sciences, 2012, 57, 2, 528

    CrossRef

  17. 17
    Anabela P. Rolo, João S. Teodoro, Carlos M. Palmeira, Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, Free Radical Biology and Medicine, 2012, 52, 1, 59

    CrossRef

  18. 18
    Klaus W Frommer, Elena Neumann, Ulf Müller-Ladner, Adipocytokines and autoimmunity, Arthritis Research & Therapy, 2011, 13, Suppl 2, O8

    CrossRef

  19. 19
    Maurizio Parola, Fabio Marra, Adipokines and Redox Signaling: Impact on Fatty Liver Disease, Antioxidants & Redox Signaling, 2011, 15, 2, 461

    CrossRef

  20. 20
    Jeffrey A. Handy, Ping P. Fu, Pradeep Kumar, Jamie E. Mells, Shvetank Sharma, Neeraj K. Saxena, Frank A. Anania, Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis, Biochemical Journal, 2011, 440, 3, 385

    CrossRef

  21. 21
    Mahnoush S. Shafiei, Shoba Shetty, Philipp E. Scherer, Don C. Rockey, Adiponectin Regulation of Stellate Cell Activation via PPARγ-Dependent and -Independent Mechanisms, The American Journal of Pathology, 2011, 178, 6, 2690

    CrossRef

  22. 22
    Kazushi Sugimoto, Yoshiyuki Takei, Clinicopathological features of non-alcoholic fatty liver disease, Hepatology Research, 2011, 41, 10
  23. 23
    Anurag Maheshwari, Paul J. Thuluvath, Endocrine Diseases and the Liver, Clinics in Liver Disease, 2011, 15, 1, 55

    CrossRef

  24. 24
    Luciano F. Drager, Jianguo Li, Christian Reinke, Shannon Bevans-Fonti, Jonathan C. Jun, Vsevolod Y. Polotsky, Intermittent Hypoxia Exacerbates Metabolic Effects of Diet-Induced Obesity, Obesity, 2011, 19, 11
  25. 25
    Yingdi Liu, Joanne Brymora, Hongyi Zhang, Briohny Smith, Mehdi Ramezani–Moghadam, Jacob George, Jianhua Wang, Leptin and Acetaldehyde Synergistically Promotes αSMA Expression in Hepatic Stellate Cells by an Interleukin 6-Dependent Mechanism, Alcoholism: Clinical and Experimental Research, 2011, 35, 5
  26. 26
    Manu Jain, G. R. Scott Budinger, Amy Lo, Daniela Urich, Stephanie E. Rivera, Asish K. Ghosh, Angel Gonzalez, Sergio E. Chiarella, Katie Marks, Helen K. Donnelly, Saul Soberanes, John Varga, Kathryn A. Radigan, Navdeep S. Chandel, Gökhan M. Mutlu, Leptin Promotes Fibroproliferative Acute Respiratory Distress Syndrome by Inhibiting Peroxisome Proliferator–activated Receptor-γ, American Journal of Respiratory and Critical Care Medicine, 2011, 183, 11, 1490

    CrossRef

  27. 27
    Sherma Zibadi, Felina Cordova, Elise H. Slack, Ronald R. Watson, Douglas F. Larson, Leptin’s regulation of obesity-induced cardiac extracellular matrix remodeling, Cardiovascular Toxicology, 2011, 11, 4, 325

    CrossRef

  28. 28
    Michiko Itoh, Takayoshi Suganami, Nobutaka Nakagawa, Miyako Tanaka, Yukio Yamamoto, Yasutomi Kamei, Shuji Terai, Isao Sakaida, Yoshihiro Ogawa, Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis, The American Journal of Pathology, 2011, 179, 5, 2454

    CrossRef

  29. 29
    Roberto Gambino, Giovanni Musso, Maurizio Cassader, Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities, Antioxidants & Redox Signaling, 2011, 15, 5, 1325

    CrossRef

  30. 30
    Jeffrey A. Handy, Neeraj K. Saxena, Pingping Fu, Songbai Lin, Jamie E. Mells, Nitika A. Gupta, Frank A. Anania, Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3), Journal of Cellular Biochemistry, 2010, 110, 5
  31. 31
    Youcai Tang, Anping Chen, Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase, British Journal of Pharmacology, 2010, 161, 5
  32. 32
    Rohit Kohli, Michelle Kirby, Stavra A. Xanthakos, Samir Softic, Ariel E. Feldstein, Vijay Saxena, Peter H. Tang, Lili Miles, Michael V. Miles, William F. Balistreri, Stephen C. Woods, Randy J. Seeley, High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis, Hepatology, 2010, 52, 3
  33. 33
    Yajun Zhou, Xin Jia, Jianbing Qin, Cuihua Lu, Huixia Zhu, Xiangyang Li, Xiao Han, Xiaoliang Sun, Leptin inhibits PPARγ gene expression in hepatic stellate cells in the mouse model of liver damage, Molecular and Cellular Endocrinology, 2010, 323, 2, 193

    CrossRef

  34. 34
    Jude A. Oben, Angelina Mouralidarane, Anne-Maj Samuelsson, Phillippa J. Matthews, Maelle L. Morgan, Chad Mckee, Junpei Soeda, Denise S. Fernandez-Twinn, Malgorzata S. Martin-Gronert, Susan E. Ozanne, Barbara Sigala, Marco Novelli, Lucilla Poston, Paul D. Taylor, Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice, Journal of Hepatology, 2010, 52, 6, 913

    CrossRef

  35. 35
    E. Velkoska, F.J. Warner, T.J. Cole, I. Smith, M.J. Morris, Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat, Nutrition, Metabolism and Cardiovascular Diseases, 2010, 20, 1, 49

    CrossRef

  36. 36
    J. K. Dowman, J.W. Tomlinson, P.N. Newsome, Pathogenesis of non-alcoholic fatty liver disease, QJM, 2010, 103, 2, 71

    CrossRef

  37. 37
    Massimo Pinzani, Jose Macias-Barragan, Update on the pathophysiology of liver fibrosis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 4, 459

    CrossRef

  38. 38
    Andrea E. Reid, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  39. 39
    Emmanuel A. Tsochatzis, George V. Papatheodoridis, Athanasios J. Archimandritis, Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy, Mediators of Inflammation, 2009, 2009, 1

    CrossRef

  40. 40
    Wing-Kin Syn, Steve S. Choi, Anna Mae Diehl, Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis, Clinics in Liver Disease, 2009, 13, 4, 565

    CrossRef

  41. 41
    Joy X. Jiang, Kenichiro Mikami, Senthil Venugopal, Yong Li, Natalie J. Török, Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathways, Journal of Hepatology, 2009, 51, 1, 139

    CrossRef

  42. 42
    Thomas Reinehr, Caroline Schmidt, Gideon de Sousa, Werner Andler, Association between leptin and transaminases: 1-year follow-up study in 180 overweight children, Metabolism, 2009, 58, 4, 497

    CrossRef

  43. 43
    Eran Elinav, Mohammad Ali, Rafi Bruck, Eli Brazowski, Adam Phillips, Yami Shapira, Meirav Katz, Gila Solomon, Zamir Halpern, Arieh Gertler, Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function, Hepatology, 2009, 49, 1
  44. 44
    Yajun Zhou, Xin Jia, Mingming Zhou, Jie Liu, Egr-1 is involved in the inhibitory effect of leptin on PPARγ expression in hepatic stellate cell in vitro, Life Sciences, 2009, 84, 15-16, 544

    CrossRef

  45. 45
    Takako Gotohda, Akiyoshi Nishimura, Kyoji Morita, Immunohistochemical studies on early stage of hepatic damage induced by subacute inhalation of toluene vapor in rats, Journal of Applied Toxicology, 2009, 29, 6
  46. 46
    Jianhua Wang, Isabelle Leclercq, Joanne M. Brymora, Ning Xu, Mehdi Ramezani–Moghadam, Roslyn M. London, David Brigstock, Jacob George, Kupffer Cells Mediate Leptin-Induced Liver Fibrosis, Gastroenterology, 2009, 137, 2, 713

    CrossRef

  47. 47
    Monique Allman, Mathew Wallace, Latausha Gaskin, Chantal A. Rivera, Leptin Induces an Inflammatory Phenotype in Lean Wistar Rats, Mediators of Inflammation, 2009, 2009, 1

    CrossRef

  48. 48
    Fabio Marra, Sara Aleffi, Sara Galastri, Angela Provenzano, Mononuclear cells in liver fibrosis, Seminars in Immunopathology, 2009, 31, 3, 345

    CrossRef

  49. 49
    Yajun Zhou, Xin Jia, Guohua Wang, Xin Wang, Jie Liu, PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells, Molecular and Cellular Biochemistry, 2009, 325, 1-2, 131

    CrossRef

  50. 50
    Tatjána Ábel, János Fehér, A nem alkoholos zsírmáj és a szív-ér rendszeri kockázat, Orvosi Hetilap, 2008, 149, 28, 1299

    CrossRef

  51. 51
    Jorge E. Toblli, Marina C. Muñoz, Gabriel Cao, José Mella, Lisandro Pereyra, Ricardo Mastai, ACE Inhibition and AT1 Receptor Blockade Prevent Fatty Liver and Fibrosis in Obese Zucker Rats, Obesity, 2008, 16, 4
  52. 52
    Zahra Ghiassi-Nejad, Scott L Friedman, Advances in antifibrotic therapy, Expert Review of Gastroenterology & Hepatology, 2008, 2, 6, 803

    CrossRef

  53. 53
    PY Zheng, Effects of puerarin on expressions of leptin receptor mRNA, phosphoryla-ted Janus kinase 2/phosphorylated signal transducers and activators of transcription 3 proteins in the liver of rats with non-alcoholic fatty liver, Journal of Chinese Integrative Medicine, 2008, 6, 9, 921

    CrossRef

  54. 54
    Ádám Eiszrich, János Fehér, Fatty Liver in Childhood, Hungarian Medical Journal, 2008, 2, 4, 519

    CrossRef

  55. 55
    Scott L. Friedman, Hepatic fibrosis—Overview, Toxicology, 2008, 254, 3, 120

    CrossRef

  56. 56
    Joy X. Jiang, Kenichiro Mikami, Vijay H. Shah, Natalie J. Torok, Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase–dependent mechanism, Hepatology, 2008, 48, 5
  57. 57
    Komal Ramani, Heping Yang, Meng Xia, Ainhoa Iglesias Ara, José M. Mato, Shelly C. Lu, Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β, Hepatology, 2008, 47, 2
  58. 58
    Sumio Watanabe, Reiko Yaginuma, Kenichi Ikejima, Akihisa Miyazaki, Liver diseases and metabolic syndrome, Journal of Gastroenterology, 2008, 43, 7, 509

    CrossRef

  59. 59
    Kyung Mook Choi, Non-alcoholic Fatty Liver Disease and Adiponectin, Korean Diabetes Journal, 2008, 32, 2, 98

    CrossRef

  60. 60
    Tatjána Ábel, János Fehér, Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk, Hungarian Medical Journal, 2008, 2, 4, 509

    CrossRef

  61. 61
    Vassilios A Sevastianos, Stephanos J Hadziyannis, Nonalcoholic fatty liver disease: from clinical recognition to treatment, Expert Review of Gastroenterology & Hepatology, 2008, 2, 1, 59

    CrossRef

  62. 62
    Joy Jiang, Natalie Torok, Nonalcoholic Steatohepatitis and the Metabolic Syndrome, Metabolic Syndrome and Related Disorders, 2008, 6, 1, 1

    CrossRef

  63. 63
    R. Urtasun, L. Conde de la Rosa, N. Nieto, Oxidative and Nitrosative Stress and Fibrogenic Response, Clinics in Liver Disease, 2008, 12, 4, 769

    CrossRef

  64. 64
    Samuele De Minicis, Ekihiro Seki, Christoph Oesterreicher, Bernd Schnabl, Robert F. Schwabe, David A. Brenner, Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells, Hepatology, 2008, 48, 6
  65. 65
    Chantal A. Rivera, Risk factors and mechanisms of non-alcoholic steatohepatitis, Pathophysiology, 2008, 15, 2, 109

    CrossRef

  66. 66
    Jianhua Wang, Joanne Brymora, Jacob George, Roles of adipokines in liver injury and fibrosis, Expert Review of Gastroenterology & Hepatology, 2008, 2, 1, 47

    CrossRef

  67. 67
    Jun Li, H.F. Si, Xiongwen Lü, Anping Guo, Hui Jiang, Suppressive effects of leflunomide on leptin-induced TIMP-1 production involves on hepatic stellate cell proliferation and apoptosis, European Journal of Pharmacology, 2008, 580, 1-2, 63

    CrossRef

  68. 68
    Cristiana Bertolani, Fabio Marra, The role of adipokines in liver fibrosis, Pathophysiology, 2008, 15, 2, 91

    CrossRef

  69. 69
    Jung Il Lee, Yong-Han Paik, Kwan Sik Lee, Jin Woo Lee, Yong Soo Kim, Seok Jeong, Kye Sook Kwon, Dong Haeng Lee, Hyung Gil Kim, Yong Woon Shin, Min Ah Kim, A peroxisome-proliferator activated receptor-γ ligand could regulate the expression of leptin receptor on human hepatic stellate cells, Histochemistry and Cell Biology, 2007, 127, 5, 495

    CrossRef

  70. 70
    Samir Parekh, Frank A. Anania, Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease, Gastroenterology, 2007, 132, 6, 2191

    CrossRef

  71. 71
    James J. Potter, Esteban Mezey, Acetaldehyde Increases Endogenous Adiponectin and Fibrogenesis in Hepatic Stellate Cells But Exogenous Adiponectin Inhibits Fibrogenesis, Alcoholism: Clinical and Experimental Research, 2007, 31, 12
  72. 72
    Zhaoyang Ye, Houssam S. Hajj Houssein, Ram I. Mahato, Bioconjugation of Oligonucleotides for Treating Liver Fibrosis, Oligonucleotides, 2007, 17, 4, 349

    CrossRef

  73. 73
    J. OCKENGA, U. J. F. TIETGE, K. H. W. BÖKER, M. P. MANNS, G. BRABANT, M. J. BAHR, Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis, Alimentary Pharmacology & Therapeutics, 2007, 25, 11
  74. 74
    Samuele De Minicis, Ekihiro Seki, Hiroshi Uchinami, Johannes Kluwe, Yonghui Zhang, David A. Brenner, Robert F. Schwabe, Gene Expression Profiles During Hepatic Stellate Cell Activation in Culture and In Vivo, Gastroenterology, 2007, 132, 5, 1937

    CrossRef

  75. 75
    Ádám Eiszrich, János Fehér, Gyermekkori zsírmáj, Orvosi Hetilap, 2007, 148, 52, 2461

    CrossRef

  76. 76
    Susanne V Fleig, Steve S Choi, Liu Yang, Youngmi Jung, Alessia Omenetti, Hendrika M VanDongen, Jiawen Huang, Jason K Sicklick, Anna Mae Diehl, Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice, Laboratory Investigation, 2007, 87, 12, 1227

    CrossRef

  77. 77
    Jens Herrmann, Axel M. Gressner, Ralf Weiskirchen, Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?, Journal of Cellular and Molecular Medicine, 2007, 11, 4
  78. 78
    Isabelle A. Leclercq, Alain Da Silva Morais, Ben Schroyen, Noémi Van Hul, Albert Geerts, Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences, Journal of Hepatology, 2007, 47, 1, 142

    CrossRef

  79. 79
    Ingrid Hickman, Graeme Macdonald, Is vitamin E beneficial in chronic liver disease?, Hepatology, 2007, 46, 2
  80. 80
    Fabio Marra, Leptin and liver tissue repair: Do rodent models provide the answers?, Journal of Hepatology, 2007, 46, 1, 12

    CrossRef

  81. 81
    Qi Cao, Ki M. Mak, Charles S. Lieber, Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells, Journal of Hepatology, 2007, 46, 1, 124

    CrossRef

  82. 82
    Eric Yan, Francisco Durazo, Myron Tong, Kurt Hong, Nonalcoholic Fatty Liver Disease: Pathogenesis, Identification, Progression, and Management, Nutrition Reviews, 2007, 65, 8
  83. 83
    Hermann E. Wasmuth, Mirko Moreno Zaldivar, Naiara Beraza, Christian Trautwein, Of mice and NASH – from fat to inflammation and fibrosis, Drug Discovery Today: Disease Models, 2007, 4, 1, 25

    CrossRef

  84. 84
    Rubén E Quirós-Tejeira, Chantal A Rivera, Taonga T Ziba, Nitesh Mehta, C Wayne Smith, Nancy F Butte, Risk for Nonalcoholic Fatty Liver Disease in Hispanic Youth With BMI ≥95th Percentile, Journal of Pediatric Gastroenterology and Nutrition, 2007, 44, 2, 228

    CrossRef

  85. 85
    Kenichi Ikejima, Kyoko Okumura, Kazuyoshi Kon, Yoshiyuki Takei, Nobuhiro Sato, Role of adipocytokines in hepatic fibrogenesis, Journal of Gastroenterology and Hepatology, 2007, 22,
  86. 86
    Dominique Pessayre, Role of mitochondria in non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, 2007, 22,
  87. 87
    Haiyan Jin, Shuji Terai, Isao Sakaida, The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis, Journal of Gastroenterology, 2007, 42, 6, 475

    CrossRef

  88. 88
    Maarouf A. Hoteit, Frank A. Anania, Treatment of fibrosis in nonalcoholic fatty liver disease, Current Gastroenterology Reports, 2007, 9, 1, 47

    CrossRef

  89. 89
    Qi Cao, Ki M. Mak, Charles S. Lieber, DLPC and SAMe combined prevent leptin-stimulated TIMP-1 production in LX-2 human hepatic stellate cells by inhibiting H2O2-mediated signal transduction, Liver International, 2006, 26, 2
  90. 90
    Don C. Rockey, Hepatic Fibrosis, Stellate Cells, and Portal Hypertension, Clinics in Liver Disease, 2006, 10, 3, 459

    CrossRef

  91. 91
    Michael R. Charlton, Paul J. Pockros, Stephen A. Harrison, Impact of obesity on treatment of chronic hepatitis C, Hepatology, 2006, 43, 6
  92. 92
    Amir Qamar, Shehzad Zafar Sheikh, Ali Masud, Muhammad Nauman Jhandier, Irteza Bin Inayat, Wyel Hakim, Wajahat Zafar Mehal, In Vitro and In Vivo Protection of Stellate Cells from Apoptosis by Leptin, Digestive Diseases and Sciences, 2006, 51, 10, 1697

    CrossRef

  93. 93
    Jie Li, Fanghong Li, Allan Zhao, Inflammation and leptin, Drug Discovery Today: Disease Mechanisms, 2006, 3, 3, 387

    CrossRef

  94. 94
    Qi Cao, Ki M. Mak, Charles S. Lieber, Leptin enhances α1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways, Journal of Cellular Biochemistry, 2006, 97, 1
  95. 95
    Sotirios K. Bethanis, Stamatios E. Theocharis, Leptin in the Field of Hepatic Fibrosis: A Pivotal or an Incidental Player?, Digestive Diseases and Sciences, 2006, 51, 10, 1685

    CrossRef

  96. 96
    Mitsuteru Kitade, Hitoshi Yoshiji, Hideyuki Kojima, Yasuhide Ikenaka, Ryuichi Noguchi, Kosuke Kaji, Junichi Yoshii, Koji Yanase, Tadashi Namisaki, Kiyoshi Asada, Masaharu Yamazaki, Tatsuhiro Tsujimoto, Takemi Akahane, Masahito Uemura, Hiroshi Fukui, Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats, Hepatology, 2006, 44, 4
  97. 97
    Neil Kaplowitz, Liver biology and pathobiology, Hepatology, 2006, 43, S1
  98. 98
    H Ogata, T Chinen, T Yoshida, I Kinjyo, G Takaesu, H Shiraishi, M Iida, T Kobayashi, A Yoshimura, Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production, Oncogene, 2006, 25, 17, 2520

    CrossRef

  99. 99
    Vishnudutt Purohit, David A. Brenner, Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman Symposium, Hepatology, 2006, 43, 4
  100. 100
    Shigeki Tsukada, Christopher J. Parsons, Richard A. Rippe, Mechanisms of liver fibrosis, Clinica Chimica Acta, 2006, 364, 1-2, 33

    CrossRef

  101. 101
    Helen Lydatakis, Ieronymos Philippos Hager, Eyaggelia Kostadelou, Stavros Mpousmpoulas, Stavros Pappas, Ioannis Diamantis, Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease, Liver International, 2006, 26, 7
  102. 102
    Cristiana Bertolani, Pau Sancho-Bru, Paola Failli, Ramon Bataller, Sara Aleffi, Raffaella DeFranco, Benedetta Mazzinghi, Paola Romagnani, Stefano Milani, Pere Ginés, Jordi Colmenero, Maurizio Parola, Stefania Gelmini, Roberto Tarquini, Giacomo Laffi, Massimo Pinzani, Fabio Marra, Resistin as an Intrahepatic Cytokine, The American Journal of Pathology, 2006, 169, 6, 2042

    CrossRef

  103. 103
    Sylvie Naveau, Gabriel Perlemuter, Muriel Chaillet, Bruno Raynard, Axel Balian, Fabienne Beuzen, Alain Portier, Pierre Galanaud, Dominique Emilie, Jean-Claude Chaput, Serum Leptin in Patients with Alcoholic Liver Disease, Alcoholism: Clinical and Experimental Research, 2006, 30, 8
  104. 104
    Eran Elinav, Asad Abd-Elnabi, Orit Pappo, Itamar Bernstein, Athalia Klein, Dean Engelhardt, Elazar Rabbani, Yaron Ilan, Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation, Journal of Hepatology, 2006, 44, 3, 529

    CrossRef

  105. 105
    Emmanuel Tsochatzis, George V Papatheodoridis, Athanasios J Archimandritis, The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases, The American Journal of Gastroenterology, 2006, 101, 11, 2629

    CrossRef

  106. 106
    Janus P. Ong, Zobair M. Younossi, Approach to the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2005, 9, 4, 617

    CrossRef

  107. 107
    Hubertus Himmerich, Christian Kaufmann, Andreas Schuld, Thomas Pollmächer, Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain, Journal of Psychiatric Research, 2005, 39, 1, 35

    CrossRef

  108. 108
    Sophie Lotersztajn, Boris Julien, Fatima Teixeira-Clerc, Pascale Grenard, Ariane Mallat, HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets, Annual Review of Pharmacology and Toxicology, 2005, 45, 1, 605

    CrossRef

  109. 109
    Haiyan Jin, Isao Sakaida, Masako Tsuchiya, Kiwamu Okita, Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet, Life Sciences, 2005, 76, 24, 2805

    CrossRef

  110. 110
    Sang Hoon Park, Choong Kee Park, Pathogenesis and Management of Non-alcoholic Steatohepatitis, Journal of the Korean Medical Association, 2005, 48, 2, 169

    CrossRef

  111. 111
    Diego Moreno Sánchez, Patogenia de la hepatopatía grasa no alcohólica primaria, Medicina Clínica, 2005, 124, 17, 668

    CrossRef

  112. 112
    F. MARRA, S. ALEFFI, C. BERTOLANI, I. PETRAI, F. VIZZUTTI, Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis, Alimentary Pharmacology & Therapeutics, 2005, 22,
  113. 113
    H. REYNAERT, A. GEERTS, J. HENRION, Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones, Alimentary Pharmacology & Therapeutics, 2005, 22, 10
  114. 114
    Qing-gao Deng, Hongyun She, Jason H. Cheng, Samuel W. French, Dennis R. Koop, Shigang Xiong, Hidekazu Tsukamoto, Steatohepatitis induced by intragastric overfeeding in mice, Hepatology, 2005, 42, 4
  115. 115
    A. M. Elsharkawy, F. Oakley, D. A. Mann, The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis, Apoptosis, 2005, 10, 5, 927

    CrossRef

  116. 116
    Xiaokun Ding, Neeraj K. Saxena, Songbai Lin, Amin Xu, Shanthi Srinivasan, Frank A. Anania, The Roles of Leptin and Adiponectin, The American Journal of Pathology, 2005, 166, 6, 1655

    CrossRef

  117. 117
    Sara Aleffi, Ilaria Petrai, Cristiana Bertolani, Maurizio Parola, Sebastiano Colombatto, Erica Novo, Francesco Vizzutti, Frank A. Anania, Stefano Milani, Krista Rombouts, Giacomo Laffi, Massimo Pinzani, Fabio Marra, Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells, Hepatology, 2005, 42, 6
  118. 118
    Hirokazu Yokoyama, Hiroshi Hirose, Hideki Ohgo, Ikuo Saito, Associations Between Serum Leptin Levels and Transaminase Activities and the Status of Lifestyle in Japanese Workers, Alcoholism: Clinical & Experimental Research, 2004, 28, Supplement, 159S

    CrossRef

  119. 119
    Hirokazu Yokoyama, Hiroshi Hirose, Hideki Ohgo, Ikuo Saito, Associations Between Serum Leptin Levels and Transaminase Activities and the Status of Lifestyle in Japanese Workers, Alcoholism: Clinical and Experimental Research, 2004, 28,
  120. 120
    C. García-Suárez, J. Crespo, P. Luis Fernández-Gil, J.A. Amado, M.T. García-Unzueta, F. Pons Romero, Concentraciones plasmáticas de leptina en los pacientes con cirrosis biliar primaria y su relación con el grado de fibrosis, Gastroenterología y Hepatología, 2004, 27, 2, 47

    CrossRef

  121. 121
    John G Kral, Swan N Thung, Simon Biron, Frederic-Simon Hould, Stefane Lebel, Simon Marceau, Serge Simard, Picard Marceau, Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis, Surgery, 2004, 135, 1, 48

    CrossRef

  122. 122
    Vlad Ratziu, Jean-Baptiste Trabut, Thierry Poynard, Fat, diabetes, and liver injury in chronic hepatitis C, Current Gastroenterology Reports, 2004, 6, 1, 22

    CrossRef

  123. 123
    D. Festi, A. Colecchia, T. Sacco, M. Bondi, E. Roda, G. Marchesini, Hepatic steatosis in obese patients: clinical aspects and prognostic significance, Obesity Reviews, 2004, 5, 1
  124. 124
    G. Brabant, H. Nave, R. Horn, C. Anderwald, G. Müller, M. Roden, In vivo and in vitro evidence for a hepatic modulation of the leptin signal in rats, European Journal of Clinical Investigation, 2004, 34, 12
  125. 125
    James J. Potter, Lynda Rennie-Tankersley, Esteban Mezey, Leptin deficiency prevents the activation of the murine α2(I) collagen promoter by acetaldehyde, Archives of Biochemistry and Biophysics, 2004, 426, 1, 73

    CrossRef

  126. 126
    Tie Lang, Kenichi Ikejima, Mutsuko Yoshikawa, Nobuyuki Enomoto, Katsuyori Iijima, Tsuneo Kitamura, Yoshiyuki Takei, Nobuhiro Sato, Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor, Biochemical and Biophysical Research Communications, 2004, 323, 3, 1091

    CrossRef

  127. 127
    Paul Angulo, Laura M. Alba, Lydia M. Petrovic, Leon A. Adams, Keith D. Lindor, Michael D. Jensen, Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease, Journal of Hepatology, 2004, 41, 6, 943

    CrossRef

  128. 128
    Dominique Pessayre, Bernard Fromenty, Abdellah Mansouri, Mitochondrial injury in steatohepatitis, European Journal of Gastroenterology & Hepatology, 2004, 16, 11, 1095

    CrossRef

  129. 129
    Leon A. Adams, Ariel Feldstein, Keith D. Lindor, Paul Angulo, Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction, Hepatology, 2004, 39, 4
  130. 130
    Anna Mae Diehl, Obesity and alcoholic liver disease, Alcohol, 2004, 34, 1, 81

    CrossRef

  131. 131
    Shiqi Yang, Ayman Koteish, Huizhi Lin, Jiawen Huang, Tania Roskams, Valina Dawson, Anna Mae Diehl, Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease, Hepatology, 2004, 39, 2
  132. 132
    B STEFANOVIC, J LINDQUIST, RA RIPPE, B SCHNABL, R SCHWABE, R BATALLER, DA BRENNER, Prevention and treatment of hepatic fibrosis at the cellular level, Journal of Gastroenterology and Hepatology, 2004, 19,
  133. 133
    B Fromenty, MA Robin, A Igoudjil, A Mansouri, D Pessayre, The ins and outs of mitochondrial dysfunction in NASH, Diabetes & Metabolism, 2004, 30, 2, 121

    CrossRef

  134. 134
    Mary E Rinella, Richard M Green, The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance, Journal of Hepatology, 2004, 40, 1, 47

    CrossRef

  135. 135
    F. Fred Poordad, The Role of Leptin in NAFLD, Journal of Clinical Gastroenterology, 2004, 38, 10, 841

    CrossRef

  136. 136
    Anna Mae Diehl, Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease, Clinics in Liver Disease, 2004, 8, 3, 619

    CrossRef

  137. 137
    Mei Tang, James J Potter, Esteban Mezey, Activation of the human α1(I) collagen promoter by leptin is not mediated by transforming growth factor β responsive elements, Biochemical and Biophysical Research Communications, 2003, 312, 3, 629

    CrossRef

  138. 138
    Stephen A Harrison, Adrian M Di Bisceglie, Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease, Drugs, 2003, 63, 22, 2379

    CrossRef

  139. 139
    A. M. Gressner, E. Yagmur, Aspekte der Pathogenese, Therapie und Diagnostik der Leberfibrose/Pathogenetic, Therapeutic and Diagnostic Aspects of Hepatic Fibrosis, LaboratoriumsMedizin, 2003, 27, 11/12, 423

    CrossRef

  140. 140
    Ariel E Feldstein, Ali Canbay, Maria E Guicciardi, Hajime Higuchi, Steven F Bronk, Gregory J Gores, Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice, Journal of Hepatology, 2003, 39, 6, 978

    CrossRef

  141. 141
    Isao Sakaida, Masako Tsuchiya, Kotarou Kawaguchi, Teruaki Kimura, Shuji Terai, Kiwamu Okita, Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet, Journal of Hepatology, 2003, 38, 6, 762

    CrossRef

  142. 142
    Ingrid J Hickman, Elizabeth E Powell, Johannes B Prins, Andrew D Clouston, Susan Ash, David M Purdie, Julie R Jonsson, In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy, Journal of Hepatology, 2003, 39, 6, 1042

    CrossRef

  143. 143
    James J Potter, Lynda Rennie-Tankesley, Esteban Mezey, Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration, Journal of Hepatology, 2003, 38, 3, 281

    CrossRef

  144. 144
    Neeraj K. Saxena, George Saliba, Jeffrey J. Floyd, Frank A. Anania, Leptin induces increased α2(I) collagen gene expression in cultured rat hepatic stellate cells, Journal of Cellular Biochemistry, 2003, 89, 2
  145. 145
    Isao Sakaida, Shen Jinhua, Koichi Uchida, Shuji Terai, Kiwamu Okita, Leptin receptor-deficient Zucker (fa/fa) rat retards the development of pig serum-induced liver fibrosis with Kupffer cell dysfunction, Life Sciences, 2003, 73, 19, 2491

    CrossRef

  146. 146
    Isabelle A Leclercq, Jacqueline Field, Geoffrey C Farrell, Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury, Gastroenterology, 2003, 124, 5, 1451

    CrossRef

  147. 147
    Scott L Friedman, Liver fibrosis – from bench to bedside, Journal of Hepatology, 2003, 38, 38

    CrossRef

  148. 148
    Jude A Oben, Tania Roskams, Shiqi Yang, Huizhi Lin, Nicoletta Sinelli, Zhiping Li, Michael Torbenson, Steven A Thomas, Anna Mae Diehl, Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice, Biochemical and Biophysical Research Communications, 2003, 308, 2, 284

    CrossRef

  149. 149
    Paolo Tessari, Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils, Current Opinion in Clinical Nutrition and Metabolic Care, 2003, 6, 1, 79

    CrossRef

  150. 150
    Andrea Bonacchi, Ilaria Petrai, Raffaella M.S Defranco, Elena Lazzeri, Francesco Annunziato, Eva Efsen, Lorenzo Cosmi, Paola Romagnani, Stefano Milani, Paola Failli, Giacomo Batignani, Francesco Liotta, Giacomo Laffi, Massimo Pinzani, Paolo Gentilini, Fabio Marra, The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C1 1The authors thank Wanda Delogu and Nadia Navari for skillful technical help, Dr. Roberto G. Romanelli for help in collecting liver biopsy specimens, and Dr. Mario Strazzabosco (Ospedali Riuniti di Bergamo, Italy) for providing part of the tissue samples with primary biliary cirrhosis., Gastroenterology, 2003, 125, 4, 1060

    CrossRef

  151. 151
    Efsevia Albanis, Rifaat Safadi, Scott L. Friedman, Treatment of hepatic fibrosis: Almost there, Current Gastroenterology Reports, 2003, 5, 1, 48

    CrossRef

  152. 152
    Fabio Marra, Leptin and liver fibrosis: A matter of fat, Gastroenterology, 2002, 122, 5, 1529

    CrossRef

  153. 153
    Mei Tang, James J Potter, Esteban Mezey, Leptin enhances the effect of transforming growth factor β in increasing type I collagen formation, Biochemical and Biophysical Research Communications, 2002, 297, 4, 906

    CrossRef

  154. 154
    Stephen A. Harrison, Shailesh Kadakia, Kevin A. Lang, Steven Schenker, Nonalcoholic steatohepatitis: what we know in the new millennium1, The American Journal of Gastroenterology, 2002, 97, 11, 2714

    CrossRef

  155. 155
    André J Scheen, Françoise H Luyckx, Obesity and liver disease, Best Practice & Research Clinical Endocrinology & Metabolism, 2002, 16, 4, 703

    CrossRef

  156. 156
    C.P. Day, Pathogenesis of steatohepatitis, Best Practice & Research Clinical Gastroenterology, 2002, 16, 5, 663

    CrossRef